Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2000;31:2685-2691

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sampei, K.
Right arrow Articles by Hsu, C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sampei, K.
Right arrow Articles by Hsu, C. Y.
Related Collections
Right arrow Gene expression
Right arrow Genetically altered mice
Right arrow Ischemic biology - basic studies
Right arrow Acute Cerebral Infarction

(Stroke. 2000;31:2685.)
© 2000 American Heart Association, Inc.


Original Contributions

Stroke Outcome in Double-Mutant Antioxidant Transgenic Mice

Kenji Sampei, MD; Allen S. Mandir, MD, PhD; Yoshio Asano, MD; Phillip C. Wong, PhD; Richard J. Traystman, PhD; Valina L. Dawson, PhD; Ted M. Dawson, MD, PhD Patricia D. Hurn, PhD

From the Departments of Anesthesiology and Critical Care Medicine (K.S., Y.A., R.J.T., P.D.H.), Neurology (A.S.M., V.L.D., T.M.D.), and Pathology (P.C.W.), Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Patricia D. Hurn, PhD, Departments of Anesthesiology/Critical Care Medicine, 600 N Wolfe St, Blalock 1404, The Johns Hopkins University School of Medicine, Baltimore, MD 21287-4961. E-mail phurn{at}jhmi.edu

Background and Purpose—Both NO and superoxide cytotoxicity are important in experimental stroke; however, it is unclear whether these molecules act within parallel pathological pathways or as coreagents in a common reaction. We examined these alternatives by comparing outcomes after middle cerebral artery occlusion in male and female neuronal NO synthase (nNOS)-deficient (nNOS-/-) or human CuZn superoxide dismutase–overexpressing (hSOD1+/-) mice and a novel strain with both mutations.

Methods—Permanent middle cerebral artery occlusion was performed by use of the intraluminal filament technique (18 hours). Neurological status was scored, and tissue infarction volume was determined by 2,3,5-triphenyltetrazolium staining and image analysis.

Results—Hemispheric infarction volume was reduced in each transgenic strain relative to the genetically matched, wild-type, control cohorts (WT mice): nNOS-/- (80±6 mm3) and double-mutant (49±6 mm3) mice versus WT mice (114±7 mm3) and hSOD1+/- mice (52±7 mm3) versus WT mice (95±5 mm3). Human CuZn superoxide dismutase had a larger effect on mean infarction volume (30% of contralateral hemisphere) than did nNOS deficiency (46%). Although infarction volume was less in double-mutant mice compared with nNOS-/- mice, injury was not improved relative to hSOD1+/- mice. There was no difference in histological damage by sex within each strain; however, female nNOS-/- mice were not protected from ischemic injury, unlike male mutants.

Conclusions—Superoxide generation contributes to severe ischemic brain injury in vivo to a greater extent than does neuronally derived NO. In vivo, significant superoxide scavenging by CuZn superoxide dismutase occurs within cellular compartments or through biochemical pathways that are not restricted to, and may be distinct from, neuronal NO/superoxide reaction and peroxynitrite synthesis.

Editorial Comment

Chung Y. Hsu, MD, PhD, Guest Editor

Department of Neurology Washington University School of Medicine St Louis, Missouri




This article has been cited by other articles:


Home page
StrokeHome page
C.-H. Chen, T. J.K. Toung, P. D. Hurn, R. C. Koehler, and A. Bhardwaj
Ischemic Neuroprotection With Selective {kappa}-Opioid Receptor Agonist Is Gender Specific
Stroke, July 1, 2005; 36(7): 1557 - 1561.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. D. Hurn, S. J. Vannucci, and H. Hagberg
Adult or Perinatal Brain Injury: Does Sex Matter?
Stroke, February 1, 2005; 36(2): 193 - 195.
[Full Text] [PDF]


Home page
StrokeHome page
P. A. Barber, L. Hoyte, F. Colbourne, and A. M. Buchan
Temperature-Regulated Model of Focal Ischemia in the Mouse: A Study With Histopathological and Behavioral Outcomes
Stroke, July 1, 2004; 35(7): 1720 - 1725.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Ishikawa, K. Y. Stokes, J. H. Zhang, A. Nanda, and D. N. Granger
Cerebral Microvascular Responses to Hypercholesterolemia: Roles of NADPH Oxidase and P-Selectin
Circ. Res., February 6, 2004; 94(2): 239 - 244.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. D. Hurn and L. M. Brass
Estrogen and Stroke: A Balanced Analysis
Stroke, February 1, 2003; 34(2): 338 - 341.
[Full Text] [PDF]


Home page
StrokeHome page
T. D. Farr and I. Q. Whishaw
Quantitative and Qualitative Impairments in Skilled Reaching in the Mouse (Mus musculus) After a Focal Motor Cortex Stroke
Stroke, July 1, 2002; 33(7): 1869 - 1875.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Goto, R. Xue, N. Sugo, M. Sawada, K. K. Blizzard, M. F. Poitras, D. C. Johns, T. M. Dawson, V. L. Dawson, B. J. Crain, et al.
Poly(ADP-Ribose) Polymerase Impairs Early and Long-Term Experimental Stroke Recovery
Stroke, April 1, 2002; 33(4): 1101 - 1106.
[Abstract] [Full Text] [PDF]